SIRT5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.42009745576865E-11 |
Normal-vs-Stage2 |
2.19849999999466E-05 |
Normal-vs-Stage3 |
1.62447832963153E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
6.595000E-01 |
Stage1-vs-Stage3 |
1.90970000035762E-07 |
Stage1-vs-Stage4 |
3.215400E-04 |
Stage2-vs-Stage3 |
1.130500E-02 |
Stage2-vs-Stage4 |
3.145700E-02 |
Stage3-vs-Stage4 |
7.311200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
2.098500E-03 |
Normal-vs-Asian |
2.899000E-01 |
Caucasian-vs-AfricanAmerican |
2.099300E-03 |
Caucasian-vs-Asian |
1.930750E-01 |
AfricanAmerican-vs-Asian |
9.486400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
3.4337976906329E-11 |
Male-vs-Female |
3.030000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.439520E-04 |
Normal-vs-Age(41-60Yrs) |
1.64646074551911E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
2.83610024354175E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.896000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.070600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.792600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.412790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.658800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.695800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.354400E-01 |
Normal-vs-Grade 2 |
1.10580433698715E-11 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
4.332400E-02 |
Grade 1-vs-Grade 3 |
7.785800E-04 |
Grade 1-vs-Grade 4 |
2.90049999995823E-06 |
Grade 2-vs-Grade 3 |
3.283300E-03 |
Grade 2-vs-Grade 4 |
2.67999999969959E-08 |
Grade 3-vs-Grade 4 |
1.227290E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.68298708302927E-12 |
Normal-vs-ccB subtype |
1.54321000422897E-14 |
ccA subtype-vs-ccB subtype |
7.095900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.31006316905768E-14 |
Normal-vs-N1 |
8.00499999999982E-05 |
N0-vs-N1 |
1.482590E-01 |
|
|